|
|
 |
AAAAI Hot Topics
The archive of AAAAI Hot Topics is listed below by title and date. The most recent Hot Topics are displayed first. Hot Topics provide summaries about newsworthy items affecting the A/I specialty. If you are an AAAAI member and wish to suggest a future Hot Topic or have comments about any of the current Hot Topics, please e-mail webeditors@aaaai.org.
Hot Topics articles are provided by AAAAI as a service to its members for educational and informational purposes only. They are provided solely on an "as is" basis and any use or reliance on the information contained in such articles is solely at the user's risk. Hot Topics articles are not intended to serve as the primary basis for making medical decisions. These articles are prepared and reviewed by AAAAI members and reflect the opinions of the author(s) and do not necessarily represent the opinions or positions of AAAAI. As with all such resources, these articles reflect medical science at the time they are written; AAAAI assumes no responsibility to update these articles or to remove them from its Web site as future developments occur.
An updated practice parameter that can be used as a ready reference for any physician who evaluates and treats patients with sinusitis.
November 29, 2005
The Diagnosis and Management of Sinusitis: A Practice Parameter Update, which is featured in the December 2005 Journal of Allergy & Clinical Immunology (JACI), was developed by the Joint Task Force on Practice Parameters for Allergy & Immunology, a joint coalition of the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology's (ACAAI), and the Joint Council of Allergy, Asthma and Immunology (JCAAI)
The United States Pharmacopia (USP)
December 1, 2005
The United States Pharmacopia (USP) is a private agency with some impact on regulation. We have recently become aware of efforts by the Joint Commission on the Accreditation of Health Care Organizations (JCAHCO) and some state legislatures to enforce USP Chapter 797-Sterile Compounding Rules-in a way which could have implications for allergists. In addition, some allergists have been told by consultants and others (incorrectly, we believe) that they must implement the requirements of the USP.
New research finds that treatment from an allergist significantly improves asthma care
November 17, 2005
Seeking asthma care from an allergist, rather than a primary care provider, can result in fewer asthma control problems and less severe symptoms. These are the findings from a new study published in the December 2005 Journal of Allergy & Clinical Immunology (JACI), the peer-reviewed, scientific journal of the AAAAI.
Center for Medicare & Medicaid Services (CMS): Physician Voluntary Reporting Program
November 2, 2005
Mark B. McClellan, M.D., Ph.D., Administrator of the CMS, announced the first step in Medicare's efforts to assess and reward the quality of physicians' care with the creation of the Physician Voluntary Reporting Program. In the first phase of the program, beginning in January 2006, Medicare will ask physicians to voluntarily report information to CMS about the quality of care they provide to Medicare beneficiaries.
Attaining Optimal Asthma Control: A Practice Parameter
October 24, 2005
Attaining Optimal Asthma Control: A Practice Parameter, which is featured in the November 2005 Journal of Allergy & Clinical Immunology (JACI), was developed by the Joint Task Force on Practice Parameters for Allergy & Immunology, a joint coalition of the American Academy of Allergy, Asthma & Immunology (AAAAI), and the American College of Allergy, Asthma & Immunology (ACAAI).
 |
Professional version: |
Based on Attaining Optimal Asthma Control: A Practice Parameter. Read more. |
|
Patient version: |
Patient Q & A |
FDA approves omalizumab (Xolair), a recombinant anti-IgE antibody, to treat moderate to severe allergic asthma
June 23, 2003
<back>
|
